"IGG is a regional medical practice comprised of board certified private practice gastroenterologists and allied professionals. We are dedicated to improving the health of our patients by providing the highest quality gastrointestinal care utilizing evidence-based medicine in a safe, compassionate manner, following clinical standards as determined by available scientific knowledge, best practice and innovative treatment."

During the past decade, Southwest Gastroenterology conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 10 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest Gastroenterology" #1 sponsor was "Allergan" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Exact Sciences Corporation" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Gastroenterology" #1 collaborator was "Ambu Inc." with 1 trials as a collaborator, "Infinite Clinical Solutions" with 1 trials as a collaborator, "Prelude Dynamics" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Gastroenterology" are "Ulcerative Colitis" (5 trials), "Gastroparesis" (4 trials), "Colorectal Cancer" (3 trials), "Diabetes Mellitus" (3 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "Southwest Gastroenterology" in a lesser frequency.

Most popular intervention types in "Southwest Gastroenterology" are "Drug" (19 trials), "Device" (2 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Etrolizumab" (3 trials), "Relamorelin" (3 trials), "Metoclopramide Nasal Spray" (2 trials) and "Placebo Nasal Spray" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Gastroenterology" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Southwest Gastroenterology". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Southwest Gastroenterology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Gastroenterology, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".